Tempest Therapeutics
TPST
TPST
31 hedge funds and large institutions have $9.88M invested in Tempest Therapeutics in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.07% less ownership
Funds ownership: 1.97% → 0.9% (-1.1%)
19% less call options, than puts
Call options by funds: $376K | Put options by funds: $466K
Holders
31
Holding in Top 10
–
Calls
$376K
Puts
$466K
Top Buyers
1 | +$1.87M | |
2 | +$617K | |
3 | +$465K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$459K |
5 |
Two Sigma Investments
New York
|
+$381K |
Top Sellers
1 | -$950K | |
2 | -$284K | |
3 | -$163K | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$159K |
5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$125K |